Cargando…
Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study
Candida albicans is the chief etiological agent of candidiasis, a mycosis prevalent in individuals with acquired immunodeficiency syndrome (AIDS). In recent years, the introduction of human immunodeficiency virus (HIV) protease inhibitors (HIV-PI) has reduced the prevalence of candidiasis in these p...
Autores principales: | Fenley, Juliana de C., de Barros, Patrícia P., do Carmo, Paulo H. F., Garcia, Maíra T., Rossoni, Rodnei D., Junqueira, Juliana C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688711/ https://www.ncbi.nlm.nih.gov/pubmed/36354676 http://dx.doi.org/10.3390/cimb44110364 |
Ejemplares similares
-
Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection
por: Rossoni, Rodnei Dennis, et al.
Publicado: (2017) -
Streptococcus mutans Can Modulate Biofilm Formation and Attenuate the Virulence of Candida albicans
por: Barbosa, Júnia Oliveira, et al.
Publicado: (2016) -
The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris
por: Rossoni, Rodnei Dennis, et al.
Publicado: (2020) -
Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir
por: Jose, Sophie, et al.
Publicado: (2017) -
Metal Nanoparticles to Combat Candida albicans Infections: An Update
por: do Carmo, Paulo Henrique Fonseca, et al.
Publicado: (2023)